Proveris accelerates the success of nasal and aerosol drug developers by providing a proven testing protocol, patented instrumentation and methodology, and a software platform that unifies all test methods, data, and analysis. Proveris provides: Comprehensive solutions for the life of a spray or aerosol drug product Effective methodology and compliance support Innovative, patented testing technologies Leading pharmaceutical companies around the world turn to Proveris for the expertise required to tackle the challenges of developing safe, effective, and innovative spray therapies. Proveris’s proven track record of dedication to customer success has made it the company pharmaceutical developers and the FDA rely on for software, instrumentation, protocols, and support for test regimes that bring next-generation spray-delivered drugs to market faster and more efficiently than ever before.
Proveris’s patented Vereo® automated actuators reliably replicate hand use of nasal and oral spray pumps and metered dose inhalers. Vereo actuator MicroDrive™ technology provides pinpoint accuracy for single-device shot weight and dose content uniformity tests. Moreover, Vereo actuators are the heart of all SprayVIEW® spray pattern and plume geometry measurement instrumentation, and the heart of Indizo® high volume, automated…
Proveris’s SprayVIEW® instrumentation established the standard now recommended by the FDA for automated spray pattern and plume geometry measurement testing of spray and aerosol delivered drugs. The patented technology provides pharmaceutical laboratories with the instrumentation needed to conduct accurate, consistent spray pattern and plume geometry tests of nasal and oral sprays, and metered dose inhalers. Features & Ben…
